Entity Common Stock, Shares Outstanding of AXIM BIOTECHNOLOGIES, INC. from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Axim Biotechnologies, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q4 2011 to Q3 2024.
  • Axim Biotechnologies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 16 Aug 2024 was 302M shares, a 27.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 302M +64.3M +27.1% 16 Aug 2024 10-Q 19 Aug 2024
Q2 2024 291M +63.8M +28% 20 May 2024 10-Q/A 22 May 2024
Q1 2024 278M +54.8M +24.5% 13 Apr 2024 10-K 16 Apr 2024
Q3 2023 238M +51.2M +27.5% 17 Oct 2023 10-Q 20 Nov 2023
Q2 2023 228M +73.4M +47.6% 22 May 2023 10-Q 22 May 2023
Q1 2023 224M +71.6M +47.1% 14 Apr 2023 10-K 17 Apr 2023
Q3 2022 186M +53.2M +39.9% 14 Nov 2022 10-Q/A 15 Nov 2022
Q2 2022 154M +25.4M +19.7% 20 May 2022 10-Q 23 May 2022
Q1 2022 152M +23.1M +18% 12 Apr 2022 10-K/A 19 Apr 2022
Q4 2021 136M +11M +8.77% 19 Nov 2021 10-Q 22 Nov 2021
Q3 2021 133M 20 Aug 2021 10-Q 23 Aug 2021
Q2 2021 129M -2.23M -1.7% 24 May 2021 10-Q/A 02 Jun 2021
Q1 2021 129M +421K +0.33% 13 Apr 2021 10-K/A 26 Apr 2021
Q4 2020 125M 18 Nov 2020 10-Q/A 27 Nov 2020
Q2 2020 131M +68.6M +110% 29 Jun 2020 10-Q/A 02 Jul 2020
Q1 2020 128M +67.4M +110% 14 May 2020 10-K/A 20 May 2020
Q3 2019 63M +3.85M +6.51% 14 Nov 2019 10-Q 14 Nov 2019
Q2 2019 62.5M +4.45M +7.67% 12 Aug 2019 10-Q 14 Aug 2019
Q1 2019 61.1M +5.55M +10% 08 Apr 2019 10-K 08 Apr 2019
Q3 2018 59.2M +4.62M +8.46% 09 Nov 2018 10-Q 14 Nov 2018
Q2 2018 58.1M +5.51M +10.5% 10 Aug 2018 10-Q/A 17 Aug 2018
Q1 2018 55.5M +2.95M +5.61% 14 Mar 2018 10-K 15 Mar 2018
Q3 2017 54.6M +7.76M +16.6% 14 Nov 2017 10-Q 20 Nov 2017
Q2 2017 52.6M +12.8M +32.2% 19 May 2017 10-Q/A 14 Sep 2017
Q1 2017 52.6M +12.8M +32.2% 29 Mar 2017 10-Q/A 14 Sep 2017
Q4 2016 51.5M +12M +30.4% 21 Nov 2016 10-Q/A 30 Nov 2016
Q3 2016 46.8M +7.44M +18.9% 20 Aug 2016 10-Q/A 25 Aug 2016
Q2 2016 39.8M 23 May 2016 10-Q/A 26 May 2016
Q1 2016 39.8M +5.74M +16.9% 13 Apr 2016 10-K/A 18 Apr 2016
Q4 2015 39.5M 16 Nov 2015 10-Q 23 Nov 2015
Q3 2015 39.4M +6.36M +19.3% 19 Aug 2015 10-Q/A 27 Aug 2015
Q1 2015 34M +1.02M +3.09% 09 Apr 2015 10-K 14 Apr 2015
Q3 2014 33M 30 Oct 2014 10-Q 14 Nov 2014
Q2 2014 33M 0 0% 14 Aug 2014 10-Q/A 26 Aug 2014
Q1 2014 33M 0 0% 30 Apr 2014 10-Q/A 18 Jun 2014
Q4 2013 33M 18 Nov 2013 10-Q 18 Nov 2013
Q2 2013 33M 0 0% 13 Aug 2013 10-Q 14 Aug 2013
Q1 2013 33M 0 0% 15 Apr 2013 10-K 15 Apr 2013
Q2 2012 33M 30 Jun 2012 10-Q 19 Nov 2012
Q1 2012 33M 16 Apr 2012 10-K/A 01 May 2012
Q4 2011 33M 15 Nov 2011 10-Q/A 21 Nov 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.